Related Experiment Video

Updated: Dec 23, 2025

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

2.9K

Pathogenic mechanisms in Huntington's disease

Lesley Jones1, Alis Hughes

  • 1MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, UK

International Review of Neurobiology
|September 13, 2011
PubMed

Insights

Huntington's disease (HD) involves CAG repeat expansions affecting gene and protein levels. Understanding these pathogenic mechanisms is crucial for developing effective therapeutic interventions for this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Huntington's disease (HD) is a progressive neurodegenerative disorder characterized by an autosomal dominant inheritance pattern.
  • The disease is caused by an expanded CAG repeat in the huntingtin (HTT) gene, but the precise pathogenic mechanisms remain incompletely understood.
  • Research has explored various hypotheses, including gene and protein-level events, somatic instability, and the role of the mutant huntingtin (mHTT) protein.

Purpose of the Study:

  • To review and elucidate the proposed pathogenic mechanisms underlying Huntington's disease.
  • To explore the consequences of CAG repeat instability and the cellular processing of the huntingtin protein.
  • To investigate the downstream effects of mutant huntingtin on cellular functions and identify potential therapeutic targets.

Main Methods:

  • Review of existing literature on Huntington's disease pathogenesis.
  • Analysis of proposed mechanisms at the gene and protein levels, including somatic instability.
  • Examination of the role of huntingtin protein aggregation, processing, and interactions.
  • Exploration of mutant huntingtin's impact on cellular degradation, transport, transcription, metabolism, and excitotoxicity.

Main Results:

  • Multiple pathogenic mechanisms, operating at both gene and protein levels, are hypothesized to contribute to HD.
  • Somatic instability of the CAG repeat is proposed to underlie striatal-specific pathology, though its exact role is unclear.
  • The form and processing of the huntingtin protein, including aggregation and post-translational modifications, are critical factors.
  • Mutant huntingtin adversely affects cellular protein degradation, transport, transcription, energy metabolism, and contributes to excitotoxicity.

Conclusions:

  • Elucidating the complex pathogenic mechanisms of Huntington's disease is essential for therapeutic development.
  • Understanding the timing and interplay of these mechanisms is a key step towards effective interventions.
  • Further research into gene and protein-level events, as well as downstream cellular effects, is warranted.

More Related Videos

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy11:22

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

8.4K
Fractionation for Resolution of Soluble and Insoluble Huntingtin Species07:08

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species

Published on: February 27, 2018

9.9K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.7K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K